Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
常見問題
Harrow Health 11.875% Senior Notes due 2027 今天的股價是多少?▼
HROWM 目前價格為 $26.03 USD,過去 24 小時下跌了 -0.08%。在圖表上更密切關注 Harrow Health 11.875% Senior Notes due 2027 股票的表現。
Harrow Health 11.875% Senior Notes due 2027 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,Harrow Health 11.875% Senior Notes due 2027 的股票以代號 HROWM 進行交易。
Harrow Health 11.875% Senior Notes due 2027 去年的營收是多少?▼
Harrow Health 11.875% Senior Notes due 2027 去年的營收為 199.61MUSD。
Harrow Health 11.875% Senior Notes due 2027 去年的淨利是多少?▼
HROWM 去年的淨收益為 -17.48MUSD。
Harrow Health 11.875% Senior Notes due 2027 會發放股息嗎?▼
是的,HROWM 的股息每 每季 發放一次。每股最新股息為 0.74 。截至今日,股息殖利率(FWD)% 為 11.41%。
Harrow Health 11.875% Senior Notes due 2027 有多少名員工?▼
截至 2026年10月16日,公司共有 217 名員工。
Harrow Health 11.875% Senior Notes due 2027 位於哪個產業?▼
Harrow Health 11.875% Senior Notes due 2027從事於Other產業。
Harrow Health 11.875% Senior Notes due 2027 何時完成拆股?▼
Harrow Health 11.875% Senior Notes due 2027 最近沒有進行任何拆股。